In the present publication various synthetic procedures are reported for previously unknown 1,4-disubstituted adamantanes, containing in particular in position I an amino acid fragment (N-benzoyl-beta-alanyloxy group). The procedures developed for modification of functional groups in the adamantane skeleton provide a possibility of synthesis of compounds with potential anticancer activity.